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A rare case is presented in this article—namely consecutive and synchronous emboliza-
tions in the pulmonary artery and paradoxical embolizations in the systemic circulation.
Although paradoxical embolizations represent a relatively rare cause of acute ischemic
attack of any localization, this nosological unit should always be considered in cases where
the source of thrombembolism is unclear, and particularly where pulmonary embolism in
the premorbid history or limb phlebothrombosis verified by sonography is present in the
history. In the acute phase of treatment it is essential to ensure surgical or endovascular
reperfusion of the ischemic organ and then at the next time to prevent further such events
especially by occlusion of patent foramen ovale.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
The incidence of paradoxical embolism is relatively low—
approximately 2% of all arterial embolizations [1,2]. Any terminal
part of the arterial bed may become the target of paradoxical
embolization; however, the most commonly involved targets
include the brain (up to 55% cases) and the limbs (up to 40%
cases) [3,4]. It has been known that the source of the embolus is
not identified in up to 40% of cerebrovascular thromboembolic
events (denoted as cryptogenic strokes in Anglo-Saxon litera-
ture), and thus the question still remains what the percentage
of paradoxical embolizations is among such cases [5,6]. In the
text below, the authors present a case report of a man
with pulmonary embolism concurrent with a massive attackch Society of Cardiology.
al in Pardubice, Division o
.
e-pardubice.cz (M. Pirkl)of paradoxical embolization in the systemic circulation—
synchronous and metachronous at the bifurcation of abdominal
aorta and in the superior mesenteric artery. The mortality of
aortic bifurcation embolism has been reported as much as up to
50% [7]; acute splanchnic ischemia due to sudden closure of the
trunk of the superior mesenteric artery (SMA) is also associated
with high mortality ranging between 50–75% [8,30].2. Case report
A male patient, 66 years of age, was transported by EMS to a
local hospital on 7 Sep 2010 due to sudden pain in both lower
limbs. In addition, the patient reported at admission that hePublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 1 4 – e 3 2 2 e315had felt pain in the chest and dyspnea day before. Personal
medical history included arterial hypertension, dyslipidemia,
permanent atrial fibrillation, status post pulmonary embolism
(anticoagulant therapy with Warfarin was stopped in 2007).
Critical acute ischemia of lower limbs was diagnosed at the
primary examination, and the patient was transferred to the
Division of Vascular Surgery of the Surgery Clinic at Regional
Hospital in Pardubice. Triplex sonography of lower limb arteries
was performed statim at the department, with the result raising
suspicion of peripheral embolization with a closure more distally
from common femoral arteries (CFA) bilaterally, therefore CT
limb angiography was performed as the next step, which
showed a saddle-shaped embolus of the abdominal aorta
spreading into the periphery (iliaco-femoral bed bilaterally)
(Fig. 1). Urgent surgical revision was indicated with indirect
embolectomy of the aorto-iliac bifurcation, and thromboembo-
lectomy from the femoral basins bilaterally, based on the
established procedure of bilateral femoral arteriotomies (the
surgery was done 4.5 hours after the aortic embolic event).Fig. 1 – Saddle embolus of the aortic bifurcation propagating to t
and lower extremities.
Fig. 2 – Embolization in the mesenteric artery about 6 cmThe patient was hospitalized at the ICU of Surgical clinic after
the procedure. The patient was sedated, artificial pulmonary
ventilation was applied, with the need of vasopressor circulatory
support initially, and continually heparinized. On 8 Sep 2010,
pulmonary spiral CT angiography and subsequently CT angio-
graphy of abdominal aorta and its branches were performed due
to clinical suspicion of pulmonary embolism based on blood gas
levels (and based on dyspnea attack inmedical history before the
event) and a rise in the intraabdominal pressure. Evidence of
pulmonary embolism was found in all branches of pulmonary
arteries bilaterally, and furthermore embolization in the superior
mesenteric artery (SMA) about 6 cm at a distance from the aorta
(Figs. 2, 3), gas in the walls of small intestinal (particularly in the
ileum), massive presence of gas in mesenteric veins, gas in
peripheral branches of the portal vein, particularly in the left
hepatic lobe (Fig. 4). Urgent surgical revision of abdominal cavity
was indicated (19 h after the first surgery), which found gangrene
of the ileum and thromboembolism of the trunk of SMA.
Embolectomy of SMAwas performed, as well as partial resectionhe both iliac arteries, CT angiography of the abdominal aorta
at a distance from the aorta, CT visceral angiography.
Fig. 3 – Closure of main branches of superior mesenteric artery by embolus, CT visceral angiography.
Fig. 4 – Massive presence of gas in mesenteric and portal veins (particulary in the left hepatic lobe) and gas in the walls of
small intestinal, CT visceral angiography—venous phase.
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After the surgery, the patient was transferred to Anesthesiology
department. The patient was ventilated for six days. The seventh
day after last surgery he was transferred back to the ICU of
surgical clinic. His condition further improved then. The nutri-
tion was combined, oral intake was gradually reinitiated, jeju-
nostomy was vital and fulfilled its elimination function. No
further complications in terms of blood perfusion of lower limbsand the gastrointestinal tract (GIT). The wounds were healing
primary. On 30 Sep 2010, echocardiography assessment was
done, transthoracic and transesophageal (both with low exam-
ination feasibility), which showed slightly abnormal IVS move-
ment, normal systolic function of LV with 70% EF, good kinetics
of the right ventricle, mild pulmonary hypertension (sPAP
40mmHg). No evidence of a thrombus in the left atrium
(including the auricle); any defect of the atrial septum was
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with the left–right and right–left short circuit (R–L short-circuit
was demonstrated by administration of an echocontrast med-
ium and also without using the Valsalva maneuver). Femoro-
popliteo-crural flebothrombosis was found in the right lower
limb based on triplex venous sonography of lower limbs.
Warfarin therapy was titrated (up to the therapeutic INR range
with the coverage using the full LMWH dose). Preliminary
hematological screening of blood coagulability disorders was
negative, and the Leiden mutation was excluded. Surgical
wounds were healing primary, no GIT passage disorders, no
signs of continued ischemization of the gastrointestinal tract; the
limbs showed palpable pulsations in the periphery bilaterally;
tendency to normalization of laboratory parameters.
Further procedure was agreed in cooperation with the
Department of Cardiology. Early stomy negation was planned
(with insertion of a caval filter before the procedure), with the
decision regarding PFO to be taken subsequently. On 8 Oct
2010, the patient was discharged to home care (efficient INR
2.6 at dimission). Admission to the Surgery Clinic of Regional
Hospital in Pardubice for jejunostomy negation was planned
for 15 Nov 2010. However, the patient suddenly died at home
on 16 Oct 2010. The autopsy found no fresh pulmonary
embolism (small pulmonary embolization was described
bilaterally); significant stenoses of coronary arteries were
determined, as well as left ventricular hypertrophy and signs
of chronic cardiac insufficiency. The autopsy also confirmed
the PFO diagnosis. Cardiorespiratory failure was determined
as the cause of death by the pathologist.3. Discussion
The incidence of paradoxical embolisms is relatively low,
forming less than 2% of system arterial embolizations [1].
The right–left short-circuit, temporary or permanent, is the
path of paradoxical embolization. The analysis of right–left
short-circuits showed that PFO was their cause in about 95%,
pulmonary arteriovenous fistulae were the causes in 4%, and
inter-atrial septum defects in 1% [9]. Other sources of para-
doxical embolism may be defects of the ventricular septum, aFig. 5 – PFO canal by TEcase report of paradoxical embolization from partially throm-
botized arteriovenous dialysis fistula [3] was described, and
also from persistent left-sided upper vena cava leading into
the superior left pulmonary vein [10].
PFO is not classified among atrial septum defects or among
cardiac defects, but it is rather understood as a relatively
common variant of the physiological condition [11]. It occurs
upon unsuccessful fusion of the primary and secondary atrial
septum. Anatomical patency of PFO persists in adult age in
about 25–30% of regular population [11]. It is found in about
20.2–34.4% of persons undergoing autopsy, with age depen-
dency [12].On one hand, PFO prevalence decrease is clearly
apparent in higher age groups (explained by possible sponta-
neous closure or premature death), [13,14] on the other, an
autopsy study showed that PFO was increasing with age in
older persons [15].Mean size of PFO is 5 mm based on autop-
sies, while Popelova´ reported the PFO range of 3–24mm [11].
Transthoracic echocardiography (US TTE) and transesophageal
echocardiography (US TEE) (Fig. 5) are used in PFO diagnostics,
including 3D and transcranial Doppler (TCD) – all these methods
also with contrast medium administration (usually agitated
physiological solution). US TEE is the gold standard of PFO
diagnostics with almost 100% sensitivity and specifity when
colored Doppler (Fig. 6) and a contrast medium are used [16].
In terms of PFO quantification, the distance of both leaves
during the Valsalva maneuver is assessed where separation
up to 2 mm means a mild defect, 2–4 mm moderate and over
4 mm means a severe defect. The right–left short-circuit is
assessed predominantly using the agitated physiological solu-
tion (Fig. 7). It is examined during respiration at rest and after
the Valsalva maneuver. The number of bubbles in a stopped
echocardiography scan is assessed where 3–10 bubbles means
a mild short-circuit, 10–20 moderate and over 20 a severe
short-circuit (however, other quantification schemes also
exist). Presence of bubbles in the left atrium to 3 cardiac
excursions from appearance of the contrast medium in the
right atrium gives evidence of a defect on the atrial level. AV
short-circuit on the pulmonary circulation level should be
considered upon later appearance of the bubbles [13].
Unlike the atrial septum defect, which signalizes fixed
(anatomical) communication between the cardiac atriumsE echocardiography.
Fig. 6 – Foramen ovale patens. Visible jet through the PFO tunnel running from left to right atrium, TEE Echogardiography.
Fig. 7 – Detection of left–right short-circuit with the use of agitated saline. The right atrium is filled with contrast medium
bubbles, bubbles penetration into the left atrium is visible, TEE echogardiography.





Causes of increased pressure in the right atrium
burden of sports chronic pulmonary disease
epistaxis pulmonary embolisation
ear decompression pulmonary arterial hypertension
pushing to excrete
stools
stenosis of the pulmonary artery
sexual intercourse tricuspid regurgitation
coughing infarction of the right atrium
Valsalva maneuver heart tamponade
diving high positive endexpiration overpressure
playing the trumpet left ventricular mechanical support of
circulation
Other causes which can lead to embolization via PFO
myocardial involvement of the right atrium
presence of the Chiari grid
changing the position with the platypnea-orthodoexia syndrome
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 1 4 – e 3 2 2e318and allowing for bidirectional flow of the blood, a functional
defect is usually present in the event of PFO, which depends
on the pressure ratio in both atriums (both components of
the atrial septum usually overlap here), not causing a sig-
nificant short-circuit as a rule. The right–left short-circuit is
present if the pressure in the right atrium exceeds the
pressure in the left atrium.
The right-sided short-circuit may be temporary or perma-
nent. It is usually caused by elevated pressure in the right
atrium [16,17]. (Table 1)
The absolute majority of persons with PFO remain asymp-
tomatic for their whole lives. However, right–left short-circuit
may start to occur with increasing pressure in the right
atrium, which may open up the possibility of paradoxical
embolization in the further course [1,3].
The criteria that alert of possible paradoxical embolism are
as follows: (1) Thromboembolization in the system arterial bed
where no source of embolization is demonstrated in left-sided
heart compartments or in the arterial bed itself (partially
thrombosed aneurysms etc.); (2) Abnormal communication
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venous thrombosis in the limbs or pulmonary embolism; (4)
Rising pressure in right-sided heart compartment that con-
tributes to the right–left short-circuit [1,18].
Any terminal part of the arterial bed may be the target of
paradoxical embolization; however, the brain (up to 55%
cases) and limbs (up to 40% cases) are involved most often
[3,4]. Other authors estimate the portion of extracerebral
paradoxical embolization only as 5–10%. In the study of
Rigatelli of 150 patients indicated for catetherization closure
of PFO or an atrial septum defect, extracerebral paradoxical
embolization was present in 9 patients (i.e. 6%), out of whom
STE myocardial infarction was present in 5 patients and
acute limb ischemia (a lower limb in all) was present in 4
cases [19].
As mentioned above, the cerebral vascular bed is the most
common target of paradoxical embolization. It is known that
the cause of 30–40% of cerebrovascular events (CVE) based on
ischemia is not sufficiently clarified (these events are denoted
as cryptogenic strokes in Anglo-Saxon literature) [5,6].This
percentage is even higher in younger patients, below 55 years
of age, where the diagnosis of cryptogenic CVE is reported for
40–60% cases [20,21]. The question still remains what the
percentage of paradoxical embolizations is among such cases.
Cryptogenic CVE and a simple proof of PFO based on imaging
methods certainly cannot be deemed equivalent. PFO was
found more often, in 40–54%, in studies on patients with a
CVE, for persons below 55 years of age and without risk factors
of a cerebrovascular event [11]. Comparing PFO incidence in
patients with cryptogenic CVE and in patients with an
explained CVE, PFO incidence was reported in 46% and 11% [21].
Metaanalysis undertaken by Overell et al. compared cryp-
togenic CVE with CVE with a known cause. Association with
cryptogenic CVEs was as follows: 22 studies reported the odds
ratio (OR) of 3.16 for PFO; OR for ASA was equal to 3.65 based
on 5 studies; and OR for PFOþASA was 23.26. Association
between cryptogenic CVE and PFO was the strongest for
patients younger than 55 years of age [14]. However, not all
studies confirmed the association between PFO and crypto-
genic CVE. The study PICCS found no relationship between
repeated CVEs and PFO presence or the magnitude of the
short-circuit through PFO [14].
In spite of clear embolic etiology in CVE with evidence of PFO,
venous thrombosis is found only in about 1/3 cases [13]. The
study that compared the incidence of deep venous thrombosis
(DVT) in patients with cryptogenic CVE compared to patients
with CVE of known etiology using MRI venography determined
more frequent incidence of DVT in patients with cryptogenic
CVE (20% vs. 4%; po0,03); similarly, the study determined also
differences in PFO incidence (59% vs. 19%; po0.001) [14].
A part of patients with PFO have also atrial septum
aneurysm (ASA). The combination of PFO with ASA and/or
Eustach valve means a higher risk of paradoxical embolism
[20]. A study was published where the atrial septum excur-
sions 45 mm (not fulfilling current ASA diagnostic criteria)
were found in patients with CVE in 55% compared to the
control group where such excursions were found only in 17%
[22]. PFO and ASA coincidence of 1% was reported; ASA was
present in about 4% of patients in the PFO group. Prevalence
of ASA alone was about 2%.The width of PFO tunnel is another risk factor for paradox-
ical embolization. Schuchlenz reported in his original paper
that PFO with the diameter of 44 mm was associated with
significant higher risk of TIA and ischemic CVE, particularly in
patients after 2 and more events [23]. Younger age (o55 years),
presence of the right–left short-circuit already at rest, and the
thrombophilic condition are also considered as risk factors for
paradoxical embolization in PFO [24].
Currently, preventive treatment is not recommended for
patients with PFO who have no other risk factors. Patients
with a lower risk are usually indicated for administration
of antiaggregation therapy (acetylosalicylic acid), while
anticoagulation therapy is recommended for patients with a
higher risk. The results of this therapy are comparable to
those of catetherization therapy. However, serious adverse
effects of anticoagulation therapy increase overall morbidity
and mortality of the patients [13]. This must be taken into
account particularly in younger patients with long life expec-
tancy given that the risk of large bleeding associated with
coumarin therapy is estimated as 1.5–11% events annually
[24]. ACCP guidelines recommend antiplatelet therapy in
patients with ischemic CVE and PFO, while anticoagulant
therapy should be reserved for patients with evidence of
deep venous thrombosis, and to patients with evidence of a
procoagulation condition and those indicated for PFO closure
where a high risk of CVE recurrence is present [24].
Currently, 4 therapeutic options are available in PFO treat-
ment in indicated cases: Antiaggregation therapy, anticoagu-
lation therapy, catetherization closure of PFO, and surgery
closure of PFO. The only 2 studies of secondary CVE preven-
tion in patients with PFO showed that the risk of recurrence is
relatively low (about 1% per year) in patients on aspirin or
short-term anticoagulation therapy [24].
Occluder therapy still remains controversial in PFO.
Although various types of occluders have been used in
Europe and Canada for PFO closure as part of CVE prevention,
FDA has not approved their use for PFO closure [12] (they
have been approved for the closure of atrial septum defects).
The first randomized, controlled study of PFO closure due to
ischemic CVE and/or TIA did not find any differences in the
primary end-point, which was defined as CVE/TIA within
2 years, overall mortality after 31 day and within 2 years
(CLOSURE I study) [25]. The occluder STARFlex closure
device (NMT Medical) was used in this study. Currently, other
studies are being conducted—CLOSE in France, PC in
Switzerland (Amplatzer PFO occluder), RESPECTwith Amplat-
zer PFO occluder and REDUCE with Helex septal occluder.
Indications for PFO closure have not been defined in any
recommendations yet. In terms of cryptogenic CVE, some
authors recommending closing all PFOs (where any unex-
plained system embolization occurred, another origin of
embolization was excluded, PFO was demonstrated, and
the right–left short-circuit was verified) [26]. French neurolo-
gists formulated other recommendations for PFO closure
(Table 2) [26]. However, the age of the patient and the patient’s
general condition must be considered. Other discussed indi-
cations include relapsing migraines, PFO in divers, and
others.
Surgical treatment is reserved for patients with PFO longer
than 25 mm, insufficient rim of the tissue around PFO, or
Table 2 – Recommendations for PFO closure after CVE
due to embolism or TIA.
1. CVE or TIAþPFO (0,6% risk/year)-aspirin
2. repeated CVE or TIAþPFO-PFO clossure
3. CVE or TIAþPFOþASA: (4% risk/year)-PFO clossure
4. CVE or TIAþPFOþDVT-PFO clossure
5. CVE or TIAþPFOþold ischemic cerebral changes on CT scan-PFO
clossure
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cal treatment of PFO in cardiosurgical patients operated for
other indications definitely seems not to be indicated. One
retrospective study showed that PFO closure in such patients
had no effect on long-term mortality, but more than doubled
the risk of CVE in the post-operation period (still during
hospitalization) compared to patients in whom PFO closure
was not performed [19].
CT pulmonary angiography is most commonly used today
for the diagnostics of pulmonary embolism, and particularly
triplex sonography for that of the deep venous thrombosis.
The therapy of paradoxical embolism is local or system
thrombolytic therapy, or therapy ensured by other radiointer-
vention methods (aspiration thrombectomy) or surgical embo-
lectomy, followed with full heparinization, with subsequent
switching of the patient to chronic anticoagulation therapy with
vitamin K antagonists or antiaggregation therapy [2]. Based on
guidelines of the Czech Cardiological Society, paradoxical embo-
lism with PFO with evidence of the right–left short-circuit, with
concurrent acute pulmonary embolism, is an indication for
thrombolytic therapy. If the target organ of paradoxical embo-
lization is not exposed to urgent risk of ischemia (grade I or IIa
for acute limb ischemia), the possibility of introducing a caval
filter can be considered in the acute phase, with concurrent
local fibrinolysis of the pulmonary artery, with or without
intraarterial thrombolysis, which reduces the right–left short-
circuit quite rapidly, besides others, and thus also the risk of
early recurrency of paradoxical embolism [6].
Aortic bifurcation embolism is one of the most serious
embolization events in the systemic circulation while
untreated it leads to death within 24–48 h. In this event, the
embolus becomes attached to the bifurcation point of the
abdominal aorta and obturates both common iliac arteries.
Sometimes, the embolus may also spread to the periphery,
which significantly worsens the prognosis of the involved
individual even after revascularization [7].
This is a sudden event, critical and rapidly progressing to
the shock condition. A typical symptom is sudden, severe
pain of lower limbs and sometimes also with propagation to
lower abdomen, while the clinical image of both lower limbs
includes all ‘‘6P’’ symptoms typical for acute limb ischemia
(pale, pulseless, painful, paralyzed, paraesthetic, perishing
with cold) [28]. The diagnosis should be apparent already
from the clinical image and/or from the sonographic finding.
Other imaging examinations may uselessly prolong the
period of limb ischemia and to further worsening of the
patient’s prognosis; however, they may be needed sometimes
to differentiate, for example, from aortic dissection.
Surgical therapy is the only proper therapy of this emer-
gency condition, which means that thrombembolectomy ofaortic bifurcation emboli and of apposition thrombi in the
peripheral bed is done alternately and repeatedly using an
embolectomic catheter, using arteriotomies in both groins, in
the common femoral arteries.
In the post-operation period, the therapy focuses on vigor-
ous anti-shock therapy and full heparinization, while
particularly the reperfusion syndrome is specific for the
post-operational period, both in the sense of threatening
compartment syndrome of the revascularized lower limbs,
and hyperkalemia from the reperfused, ischemically
damaged soft tissues of the limbs, and acute renal insuffi-
ciency as a result of myoglobin precipitation in renal tubules
with their necrosis. Mortality of this nosological unit ranges
between 30–50% [7].
The incidence of acute mesenteric ischemia (AMI) in
autoptic studies is 5.3–8.6/100000 autopsies [29].
Emboligenic etiology represents approximately 50% of all
mesenteric ischemias (28–60%), and thrombotic approxi-
mately 25% (8.5–64%); mesenteric venous thrombosis is
represented in 5–15% of all acute mesenteric ischemias
(AMI) and nonocclusive mesenteric ischemia is described in
20–30% of all cases [30].
In initial stages, clinical symptoms are very low in contrast
to subjective complaints and reports of the patient. The
symptoms include nausea, anorexia, fever, vomiting or diar-
rhea, melena, enterorrhagia. The first attack with vomiting
and severe abdominal pain, accompanied with low clinical
finding, lasts approximately 6 h. A period of relative subjec-
tive calming of the patient follows for the next approximately
6 h as a rule; however, the critical condition continues and
deepens, it is an image of paralytic ileus; the next phase is
gangrene of the intestinal wall with peritoneal symptoms
[31]. Emboligenic AMI should be considered always when
severe abdominal pain occurs in a patient with the history of
recent myocardial infarction, cardiac arrhythmia, cardiomyo-
pathy or valvulvar defect or replacement. AMI diagnosis can
be determined in most cases based on contrast CT with i.v.
administration of contrast medium bolus. Alternatively, an
even more specific image can be provided by visceral angio-
CTor even selective mesenterial catetherization angiography.
Another option is the laparoscopic revision after intravenous
fluorescein application and exploration of the abdominal
cavity in ultraviollet light. [32].
Ischemic tolerance of the intestine has been reported as
120–180 min. Generally, every patient with this diagnosis
should be revised through surgery, in particular considering
the extensive collateral network that supplies the intestine
and the possibility of embolization into more peripheral
branches of the SMA, while depending precisely on these
factors, intestinal viability may be prolonged up to several
hours or days [7]. Generally accepted time limit that still
allows for achieving full recovery after the revascularization
procedure is the first 6 h from the onset of the symptoms [31].
Hospitalization mortality reaches 50–75% even today [8].
Surgical therapy of arterio-occlusive AMI (emboligenic or
thrombotic) predominates, while for the therapy to be success-
ful, it must be timely. In the event of emboligenic closure,
surgical embolectomy of the superior mesenteric artery should
be done, and bypass surgery or thrombectomy with a patch
angioplasty of the stenotized superior mesenteric artery if the
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surgery and the bypass should be constructed from an auto-
logous graft of vena saphena magna if possible—particularly in
the event of gangrenous changes of the intestine with the need
of its resection due to concerns about a possible infection of
the prosthetic graft, which could be fatal for the patient. Bypass
inflow is recommended from the supraceliacal aorta (athero-
sclerotic changes are seldom expressed here), but proximal
anastomosis may be constructed also in the subrenal aorta or
iliac artery. The outflow should be constructed into freely
patent superior mesenteric artery, distally from the stenotic-
occlusive process.
There is also a possibility of intervention therapy that
includes particularly aspiration thrombectomy and stenting
of the sclerotically stenotized AMS. However, this procedure
is very demanding in terms of coordination of the teams,
and it entails the essential disadvantage of missing direct
revision and clarification of advancement of intestinal ische-
mia [30].
In his set, Edwards describes 76 patients with AMI during
10 years. 16 of these patients ended up with mere exploration
laparotomy for extensive intestinal gangrene incompatible
with life. Only resection surgery in the intestine with no
revascularization was performed in 18 patients, and revascu-
larization was done in 43 patients (this set included 28
patients with concurrent resection of the ischemic part of
the digestive tract). In further development, 44 patients
underwent second-look laparotomy and one half also
another intestinal resection due to continued ischemia. This
set achieved hospitalization mortality of 62%, but moreover,
31% of the survivors ended up with the short bowel syn-
drome, on long-term parenteral nutrition at home [33].
The Edwards’s set included 32 patients with AMI emboliza-
tion etiology, while another synchronous embolization
occurred in 10 cases (31%), which was synchronous emboli-
zation in lower limbs in 9 of these cases [33].4. Conclusion
A rare case (no similar found in literature) was presented in
the previous case report summary, namely consecutive
and synchronous embolizations in the pulmonary artery
and paradoxical embolizations in the systemic circulation.
Although paradoxical embolizations represent a relatively
rare cause of acute ischemic attack of any localization, this
nosological unit should always be considered in cases where
the source of thrombembolism is unclear, and particularly
where pulmonary embolism in the premorbid history or limb
phlebothrombosis verified by sonography is present in the
history.
Both the therapy and prognosis of any patient with para-
doxical embolism is always given by the anatomical area
involved, by the scope and duration of ischemia of the target
organ whose arterial perfusion was thus affected. Therapy
not only of the target and source of the embolism but also
precisely of PFO is important for further fate of surviving
patients.r e f e r e n c e s
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